Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant, Bausch & Lomb And The Long Reach Of Fred Hassan
Pharmalot
Tuesday, May 28, 2013 - 10:56am
tags:
Valeant Pharmaceuticals, Bausch & Lomb, Fred Hassan
Prosensa IPO Filing Looks Good For Sarepta Therapeutics
TheStreet.com
Tuesday, May 28, 2013 - 10:54am
tags:
IPOs, Prosensa, Sarepta Therapeutics, GSK
Siga Rises on Chance to Reargue PharmAthene Damages
Bloomberg
Tuesday, May 28, 2013 - 10:53am
tags:
PharmAthene, SIGA technologies, ST-246
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha
Tuesday, May 28, 2013 - 9:30am
tags:
asthma, Sanofi, Regeneron, dupilumab
Chronic disease conditions could attract pharma-accountable care organization collaboration
FT.com
Tuesday, May 28, 2013 - 8:58am
tags:
chronic disease, ACOs
Omthera shares up 89% after AstraZeneca deal
Marketwatch
Tuesday, May 28, 2013 - 8:36am
tags:
Omthera, M&A, AstraZeneca
Valeant: FDA Rejects Nail Fungus Treatment Efinaconazole Over Container
FOX Business
Tuesday, May 28, 2013 - 8:35am
tags:
FDA, Valeant Pharmaceuticals, nail fungus, efinaconazole
J&J's DePuy can't dodge $8.3M metal hip implant verdict
Mass Device
Tuesday, May 28, 2013 - 8:32am
tags:
JNJ, DePuy, hip implants, settlements, devices
Oasmia Rises on New Cancer Combination Drug
Bloomberg
Tuesday, May 28, 2013 - 8:31am
tags:
Oasmia, cancer
Pharmaxis slashes staff after FDA red-flags cystic fibrosis treatment
Fierce Biotech
Tuesday, May 28, 2013 - 8:26am
tags:
FDA, Pharmaxis, layoffs, cystic fibrosis, Bronchitol
Alexion snags latest 'breakthrough' coup with PhIII rare-disease drug
Fierce Biotech
Tuesday, May 28, 2013 - 8:25am
tags:
Alexion, asfotase alfa, hypophosphatasia
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
Seeking Alpha
Tuesday, May 28, 2013 - 8:14am
tags:
BioDelivery Sciences, Acadia, Amarin, Keryx, Insmed, opiod addiction
NeoStem: A Biotech With Lots Of Promise
Seeking Alpha
Tuesday, May 28, 2013 - 8:12am
tags:
NeoStem
Big Pharma Wants Fish Oil After All, But At Half Amarin's Selling Price
TheStreet.com
Tuesday, May 28, 2013 - 7:33am
tags:
Amarin, Vascepa, GSK, AstraZeneca, M&A, Omthera
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Monday, May 27, 2013 - 8:17pm
tags:
Biogen Idec, Rituxan, TG Therapeutics, Utuxin, TGR-1202, CLL, chronic lymphocytic leukemia, non-Hodgkin's lymphoma
Booming Irish pharmaceutical sector sets sights on China
China Daily
Monday, May 27, 2013 - 10:41am
tags:
Ireland, China
3 Things About to Move Pfizer Stock
Motley Fool
Monday, May 27, 2013 - 10:36am
tags:
Pfizer, Zoetis, Xeljanz, Prevnar 13
Sun Pharma rallies on German firm buyout buzz
Economic Times, India
Monday, May 27, 2013 - 10:19am
tags:
Sun Pharma, Stada, M&A, India
Valeant pays $8.7 billion for Bausch & Lomb
CNN Money
Monday, May 27, 2013 - 10:12am
tags:
Valeant Pharmaceuticals, Bausch & Lomb, M&A
Heart device approval delays leave US doctors frustrated
Reuters
Monday, May 27, 2013 - 10:10am
tags:
devices, Edwards Lifesciences, Heart Devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.